Distribution of C-reactive protein and its relation to arterial hypertension in a country representing a high-risk region for cardiovascular diseases

Blood Pressure

Volumn 15, Issue 1, 2006, Pages 20-26

  Zdrojewski, Tomasz ^a   Chwojnicki, Kamil ^a   Bandosz, Piotr ^a   Konarski, Roman ^b   Wyrzykowski, Bogdan ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF GDA SK   (Poland)

Author keywords

Arterial hypertension; C reactive protein; Cross sectional survey

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE;

ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF COVARIANCE; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLAND; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; ENDEMIC DISEASES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLAND; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 33644608788     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050500450049     Document Type: Article

References (22)

1. Rocznik demograficzny (Demographic Yearbook).(2002) Warszawa. In.
2. (2002) The European Health Report 2002. WHO Reg Publ Eur Ser, 97, pp. 2 - 5.
3. Kaplan, N. M.(1990) Clinical hypertension. 5. Baltimore: Williams and Wilkins.
4. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. (2003) Guidelines Committee. J Hypertens, 21, pp. 1011 - 1053.
5. Pearson, T. A. and Mensah, G. A. and Alexander, R. W. and Anderson, J. L. and Cannon, R. O., 3rd and Criqui, M. and (2003) Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, pp. 499 - 511.
6. (2001) Executive Summary of the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA, 285, pp. 2486 - 2497.
7. Wilson, P. W. and D'Agostino, R. B. and Levy, D. and Belanger, A. M. and Silbershatz, H. and Kannel, W. B. (1998) Prediction of coronary heart disease using risk factor categories. Circulation, 97, pp. 1837 - 1847.
8. Ridker, P. M. (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 107, pp. 363 - 369.
9. Zdrojewski, T. and Szpakowski, P. and Bandosz, P. and Pajak, A. and Wiecek, A. and Krupa-Wojciechowska, B. and (2004) Arterial hypertension in Poland in 2002. J Hum Hypertens, 18, pp. 557 - 562.
10. Steczkowski, J.(1995) Representative survey in economic and social research. In. Warszawa-Kraków: Wydawnictwo Naukowe PWN.
11. (1999) Guidelines subcommittee: 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens, 17, pp. 151 - 183.
12. Danesh, J. and Muir, J. and Wong, Y. K. and Ward, M. and Gallimore, J. R. and Pepys, M. B. (1999) Risk factors for CAD and acute-phase proteins. Eur Heart J, 20, pp. 954 - 959.
13. Neter, J. and Kutner, M. H. and Nachtsheim, C. J. and Wasserman, W.(1996) Applied linear statistical models. 4. Chicago IL: Irwin.
14. Hajjar, I. and Kotchen, T. A. (2003) Trends in prevalence, awareness, treatment, and control of hypertension in the United States. JAMA, 290, pp. 199 - 206.
15. Albert, M. A. and Glynn, R. J. and Ridker, P. M. (2003) Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation, 108, pp. 161 - 165.
16. Koenig, W. and Löwel, H. and Baumert, J. and Meisinger, C. (2004) C-reactive protein modulates risk prediction based on the Framingham Score. Implications for future risk assessment: Results from a large cohort study in Southern Germany. Circulation, 109, pp. 1349 - 1353.
17. Ridker, P. M. and Rifai, N. and Rose, L. and Buring, J. E. and Cook, N. R. (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 347, pp. 1557 - 1565.
18. Danesh, J. and Wheeler, J. G. and Hirschfield, G. M. and Eda, S. and Eiriksdottir, G. and Rumley, A. and (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med, 350, pp. 1387 - 1397.
19. Van der Meer, I. M. and de Maat, M. P. and Kiliaan, A. J. and van der Kuip, D. A. and Hofman, A. and Witteman, J. C. (2003) The value of C-reactive protein in cardiovascular risk prediction: The Rotterdam Study. Arch Intern Med, 163, pp. 1323 - 1328.
20. The Expert Committee. (2003) National Cardiovascular Disease Prevention and Treatment Program for years 2003-2005. POLKARD 2003-2005. Kardiologia Polska, 59, pp. 535 - 544.
21. Niskanen, L. and Laaksonen, D. E. and Nyyssonen, K. and Punnonen, K. and Valkonen, V. P. and Fuentes, R. and (2004) Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension, 44, pp. 1 - 7.
22. Blake, G. I. and Rifai, N. and Buring, J. E. and Ridker, P. M. (2003) Blood pressure, C-reactive protein and risk of future cardiovascular events. Circulation, 108, pp. 994 - 1000.